Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Satraplatin plus Prednisone in HRPC
NCT00069745Phase 3Completed
- Sponsor
- Agennix AG
- Start
- Sep 2003
- Primary completion
- Jan 2006
- Modality
- DNA Intercalators/Alkylators
- Countries
- 15
01
Overview
A Phase 3 trial of satraplatin in prostate cancer (PCa), sponsored by Agennix AG. Started Sep 2003; status: completed.
02
Drugs
satraplatin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00069745.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00069745.